Grade ≥ 3 adverse events in ≥ 2 patients
| Preferred term . | N = 299 (%) . |
|---|---|
| Any AE of grade ≥ 3 severity, n (%) | 83 (28) |
| Thrombocytopenia | 7 (2) |
| ALT increased | 6 (2) |
| Fatigue | 6 (2) |
| Pain in extremity | 5 (2) |
| Anemia | 4 (1) |
| Aspartate aminotransferase increased | 4 (1) |
| Back pain | 4 (1) |
| Hypertension | 4 (1) |
| Myocardial infarction | 4 (1) |
| Abdominal pain | 3 (1) |
| Blood bilirubin increased | 3 (1) |
| Cataract | 3 (1) |
| Dyspnea | 3 (1) |
| Menorrhagia | 3 (1) |
| Pneumonia | 3 (1) |
| Arthritis | 2 (< 1) |
| Chest pain | 2 (< 1) |
| Deep vein thrombosis | 2 (< 1) |
| Diarrhea | 2 (< 1) |
| Dizziness | 2 (< 1) |
| Gastrointestinal hemorrhage | 2 (< 1) |
| Headache | 2 (< 1) |
| Insomnia | 2 (< 1) |
| Migraine | 2 (< 1) |
| Renal failure | 2 (< 1) |
| Preferred term . | N = 299 (%) . |
|---|---|
| Any AE of grade ≥ 3 severity, n (%) | 83 (28) |
| Thrombocytopenia | 7 (2) |
| ALT increased | 6 (2) |
| Fatigue | 6 (2) |
| Pain in extremity | 5 (2) |
| Anemia | 4 (1) |
| Aspartate aminotransferase increased | 4 (1) |
| Back pain | 4 (1) |
| Hypertension | 4 (1) |
| Myocardial infarction | 4 (1) |
| Abdominal pain | 3 (1) |
| Blood bilirubin increased | 3 (1) |
| Cataract | 3 (1) |
| Dyspnea | 3 (1) |
| Menorrhagia | 3 (1) |
| Pneumonia | 3 (1) |
| Arthritis | 2 (< 1) |
| Chest pain | 2 (< 1) |
| Deep vein thrombosis | 2 (< 1) |
| Diarrhea | 2 (< 1) |
| Dizziness | 2 (< 1) |
| Gastrointestinal hemorrhage | 2 (< 1) |
| Headache | 2 (< 1) |
| Insomnia | 2 (< 1) |
| Migraine | 2 (< 1) |
| Renal failure | 2 (< 1) |
AE indicates adverse event; ALT, alanine aminotransferase; and AST, aspartate aminotransferase.